A couple of numbers really jumped out at me on Wednesday when Hillenbrand Inc. announced that it’s selling the majority of its Milacron injection molding and extrusion machinery business to an affiliate of Bain Capital for $287 million.
Hillenbrand has only owned Milacron since 2019, when it paid $1.9 billion for Milacron Holdings Corp. I did a double take, and I’m sure Plastics News readers did too — exactly how much value did Milacron lose in just six years?
Global plastics machinery has been in a recession since the pandemic, so it’s not exactly a market where I’d recommend that widows and orphans put all their savings. But the numbers aren’t as bleak as they first appear.
First, remember that Bain is buying just a 51 percent stake in the business. And second, keep in mind that when Hillenbrand bought Milacron Holdings Corp., it was not just "Milacron." That $1.9 billion deal also included DME and Mold-Masters. Those businesses aren’t included in the sale to Bain Capital.
There’s one more number to remember: When Hillenbrand bought Milacron, that also included Cimcool, which makes metalworking fluids and equipment. Cimcool wasn’t really a good fit with the plastics operations, so Hillenbrand sold Cimcool to Dubois Chemical Inc. for $224 million in 2020.So let’s break down what Bain is buying vs. what Hillenbrand is keeping. That’s pretty simple because Hillenbrand already reports the sales and EBITDA separately. In fiscal year 2024, Milacron’s machinery business generated $526 million in sales and $64 million in adjusted EBITDA.
Hillenbrand’s Molding Technology Solutions business — basically DME and Mold-Masters — posted 2024 sales of $895 million and adjusted EBITDA of $143 million. That’s quite a bit larger than the machinery business.
And don’t forget that Hillenbrand is keeping a 49 percent stake in the machinery business. That suggests that Hillenbrand still has confidence in Milacron’s potential — although keeping a minority stake will reduce the company’s direct exposure to the cyclicality of plastics machinery.
I apologize for all the numbers, but I think they help explain how two deals for Milacron went from $1.9 billion to $287 million in just six years. And what really matters to our readers will be the future of the Milacron, DME and Mold-Masters brands (not to mention the other plastics machinery brands Hillenbrand owns that aren’t included in this deal, including Coperion and Herbold).